Anti-tuberculosis effect of microbiome therapeutic PMC205 in extensively drug-resistant pulmonary tuberculosis in vivo.

Hoonhee SeoYoujin YoonSukyung KimFatemeh GhorbanianHanieh TajdozianSujin JoIndrajeet BarmanSoyeon LeeYoungkyoung LeeMd Abdur RahimMohammed Solayman HossainSaebim LeeHo-Yeon Song

Published in: International journal of antimicrobial agents (2024)

These results confirm PMC205's anti-tuberculosis effect, suggesting that it can be developed as an adjuvant to current antibiotic therapy to solve the drug-resistant tuberculosis problem.

Keyphrases

drug resistant
pulmonary tuberculosis
multidrug resistant
mycobacterium tuberculosis
acinetobacter baumannii
stem cells
mesenchymal stem cells
pseudomonas aeruginosa
cystic fibrosis
cell therapy
replacement therapy